[{"id":"cms88yws8b4fpkh0cfl21p8w0","channel":"knowledge","topic":"papers-medrxiv","title":"Changing epidemiology and transmission dynamics of measles in Ho Chi Minh City: a comparison of the 2018-2020 and 2024-2025 outbreaks","summary":"Introduction Measles remains a major public health threat worldwide. Following a resurgence of cases, Ho Chi Minh City (HCMC) experienced a severe outbreak in 2024-2025 that differed from the 2018-2020 epidemic. We compared the epidemiology and transmission dynamics of these two outbreaks to inform ","payload":{"doi":"10.64898/2026.07.27.26358995","url":"https://www.medrxiv.org/content/10.64898/2026.07.27.26358995v1","title":"Changing epidemiology and transmission dynamics of measles in Ho Chi Minh City: a comparison of the 2018-2020 and 2024-2025 outbreaks","source":"medrxiv","authors":"Truong Thi Thanh, L.; Huynh, A.; Huynh, K.; Le, K. D.; Pham, T.; Tran, A.; Pham Thi Kim, T.; Thanh Nguyen, T.; Le Hong, N.; Nguyen Hong, T.; Ong, T.; Thai Thanh, T.","version":"1","abstract":"Introduction Measles remains a major public health threat worldwide. Following a resurgence of cases, Ho Chi Minh City (HCMC) experienced a severe outbreak in 2024-2025 that differed from the 2018-2020 epidemic. We compared the epidemiology and transmission dynamics of these two outbreaks to inform future surveillance and vaccination strategies. Methods Line-list data for measles cases reported in HCMC between 2018 and 2025 were extracted from the infectious disease surveillance system. Demographic changes were assessed using cross-sectional age distributions and longitudinal birth-cohort analyses. Transmission dynamics were characterized by estimating the effective reproduction number (Rt) using the Cori and Wallinga-Teunis methods. Age-stratified Who-Infected-Whom transmission matrices were constructed to quantify within- and between-age-group transmission before and after interventions. Results The 2018-2020 outbreak primarily affected children under five years of age (median age 3.75 years, IQR 0.9-9.1), whereas the 2024-2025 outbreak shifted toward older age groups (median age 8.4 years, IQR 1-14). Birth-cohort analyses identified two major immunity gaps: children born during ","category":"epidemiology","published_at":"2026-07-28T00:00:00.000Z","corresponding_author":"Thinh Ong","journal_published_doi":null,"corresponding_institution":"Oxford University Clinical Research Unit"},"public_metadata":null,"published_at":"2026-07-31T01:11:50.648Z"},{"id":"cms88yw8mb4fnkh0ce98li3u7","channel":"knowledge","topic":"papers-medrxiv","title":"Deep Learning-Based Pretreatment Cardiovascular Risk Stratification in Women with Breast Cancer","summary":"Background: Cardiovascular disease is a leading non-cancer cause of morbidity and mortality among breast cancer (BC) survivors. Existing cardiovascular risk tools are not tailored to cancer populations and often rely on cardiology investigations or treatment details unavailable at the initial oncolo","payload":{"doi":"10.64898/2026.07.26.26350307","url":"https://www.medrxiv.org/content/10.64898/2026.07.26.26350307v1","title":"Deep Learning-Based Pretreatment Cardiovascular Risk Stratification in Women with Breast Cancer","source":"medrxiv","authors":"Dehghan Manshadi, M.; Manouchehri, N.; Hubbert, L.; Liljegren, A.; Manouchehrinia, A.; Linder-Stragliotto, C.; Rantala, J.; Hedayati, E.; Kiani, N.","version":"1","abstract":"Background: Cardiovascular disease is a leading non-cancer cause of morbidity and mortality among breast cancer (BC) survivors. Existing cardiovascular risk tools are not tailored to cancer populations and often rely on cardiology investigations or treatment details unavailable at the initial oncology visit, limiting their use for early referral decisions. Methods: We conducted a registry-based cohort study including 17,051 women diagnosed with BC in stage I-III or ductal carcinoma in situ in the Stockholm-Gotland region (2008-2019). Using only pre-treatment information routinely available to oncologists, such as demographics, cancer characteristics, planned cancer treatment, baseline comorbidities, medications, and healthcare utilization, we trained and validated a deep learning-based competing-risk model to predict 1-year major adverse cardiovascular events (MACE) risk, accounting for non-cardiovascular death as a competing outcome. Model performance was evaluated using a 3-fold CV and time-dependent concordance indices. Fine-Gray subdistribution hazard models were used to aid interpretability. Results: The model demonstrated strong and stable discrimination across validation fol","category":"epidemiology","published_at":"2026-07-28T00:00:00.000Z","corresponding_author":"Mehdi Dehghan Manshadi","journal_published_doi":null,"corresponding_institution":"Karolinska Institutet"},"public_metadata":null,"published_at":"2026-07-31T01:11:49.943Z"},{"id":"cms88yvp7b4flkh0civb20od9","channel":"knowledge","topic":"papers-medrxiv","title":"Can non-routine data collection help decision-making for gambiense sleeping sickness? Using active adaptive management to assess the potential of vector control","summary":"Gambiense human African trypanosomiasis (gHAT) is a vector-borne disease, spread by tsetse, found in West and Central Africa. It has been targeted for elimination of transmission (EoT) by the World Health Organization: the reduction to zero of the incidence of infection, with minimal risk of reintro","payload":{"doi":"10.64898/2026.07.27.26359007","url":"https://www.medrxiv.org/content/10.64898/2026.07.27.26359007v1","title":"Can non-routine data collection help decision-making for gambiense sleeping sickness? Using active adaptive management to assess the potential of vector control","source":"medrxiv","authors":"Sunnucks, R.; Tirados, I.; Mwamba Miaka, E.; Davis, E. L.; Rock, K. S.","version":"1","abstract":"Gambiense human African trypanosomiasis (gHAT) is a vector-borne disease, spread by tsetse, found in West and Central Africa. It has been targeted for elimination of transmission (EoT) by the World Health Organization: the reduction to zero of the incidence of infection, with minimal risk of reintroduction. Many high-risk regions have implemented vector control (VC), in addition to medical interventions, to reduce the spread of gHAT and reach EoT. There exists uncertainty around the effectiveness of VC interventions, and so the impact of VC can be measured through deploying traps, which estimate changes in the tsetse population. In this study, we use mathematical transmission modelling to assess the added monetary value of entomological monitoring data in strategy selection for two health zones of the Democratic Republic of Congo, illustratively chosen because of their different levels of uncertainty on VC effectiveness. We used active adaptive management (AAM) - the process of updating our strategy based on collected data (i.e. choosing to continue or stop VC based on perceived effectiveness), where posterior distributions on VC effectiveness were calculated with an adaptive MCMC ","category":"epidemiology","published_at":"2026-07-28T00:00:00.000Z","corresponding_author":"Rob Sunnucks","journal_published_doi":null,"corresponding_institution":"University of Warwick"},"public_metadata":null,"published_at":"2026-07-31T01:11:49.243Z"},{"id":"cms88yv5lb4fjkh0cm4jb8ln2","channel":"knowledge","topic":"papers-medrxiv","title":"Automated epidural spinal cord stimulation for cardiovascular regulation in spinal cord injury: from optimization to real-time implementation","summary":"Background: Spinal cord injury (SCI) is frequently associated with orthostatic hypotension, defined by a sustained decrease in blood pressure upon assuming an upright posture due to impaired autonomic regulation. Cardiovascular spinal cord epidural stimulation (CV-scES) can regulate systolic blood p","payload":{"doi":"10.64898/2026.07.21.26358253","url":"https://www.medrxiv.org/content/10.64898/2026.07.21.26358253v1","title":"Automated epidural spinal cord stimulation for cardiovascular regulation in spinal cord injury: from optimization to real-time implementation","source":"medrxiv","authors":"Christie, B.; Wang, S.; Ledbetter, H.; Diaz, L.; Nguyen, H.; Forrest, G. F.; Torgerson, N.; Angeli, C. A.; Johnson, E. C.; Harkema, S. J.; Tenore, F. V.","version":"1","abstract":"Background: Spinal cord injury (SCI) is frequently associated with orthostatic hypotension, defined by a sustained decrease in blood pressure upon assuming an upright posture due to impaired autonomic regulation. Cardiovascular spinal cord epidural stimulation (CV-scES) can regulate systolic blood pressure (SBP) in people with SCI, but stimulation paradigms are highly individualized. To make this treatment available to more patients, we developed an algorithm to tailor individualized CV-scES paradigms that closely mimic researcher-developed paradigms. Methods: We performed an offline analysis using datasets collected from eight individuals with SCI with epidural stimulators implanted over the lumbosacral spinal segments. During data collection, researchers modulated stimulation parameters with the goal of maintaining SBP between 110-120 mmHg. Each two-hour dataset included synchronized SBP and stimulation recordings. We ran optimization analyses offline to determine temporal requirements before modifying stimulation amplitude to mitigate out-of-range SBP. Results: The algorithm parameters that best matched researcher-selected stimulation changed relatively quickly during the first ","category":"cardiovascular medicine","published_at":"2026-07-28T00:00:00.000Z","corresponding_author":"Breanne Christie","journal_published_doi":null,"corresponding_institution":"Johns Hopkins University Applied Physics Laboratory"},"public_metadata":null,"published_at":"2026-07-31T01:11:48.513Z"},{"id":"cms88yukub4fhkh0cbcj38l9o","channel":"knowledge","topic":"papers-medrxiv","title":"Biomarkers of protection against controlled human SARS-CoV-2 Delta variant breakthrough infection","summary":"Background Improved understanding of how variants cause breakthrough infection, despite pre-existing immunity, is needed to advance development of next-generation SARS-CoV-2 vaccines, including those that may provide cross-variant protection or block transmission. SARS-CoV-2 controlled human infecti","payload":{"doi":"10.64898/2026.07.24.26358855","url":"https://www.medrxiv.org/content/10.64898/2026.07.24.26358855v1","title":"Biomarkers of protection against controlled human SARS-CoV-2 Delta variant breakthrough infection","source":"medrxiv","authors":"Singanayagam, A.; Wagstaffe, H. R.; Slater, L. J.; Fox-Sheehan, P.; Wu, M.-S.; Mawer, A.; Scott, H.; Daly, O.; Low, J. M.; Lopez Ramon, R.; Hughes, E.; Zhou, J.; Badhan, A.; Guy, J.; Harris, S.; Smith, S. P.; Govender, M.; Laidlaw, S.; Tipton, T.; Satti, I.; Yaden, M.; Ascough, S. C.; Sukhova, K.; Moshe, M.; McKenzie, J.; Siddiqui, H.; Ateere, A.; Francis, B.; Stiff, F.; Khoury, D.; Reynaldi, A.; Davenport, M.; Carroll, M.; Thwaites, R. S.; Taylor, G. P.; Barclay, W. S.; Bracchi, M.; McShane, H.; Chiu, C.","version":"1","abstract":"Background Improved understanding of how variants cause breakthrough infection, despite pre-existing immunity, is needed to advance development of next-generation SARS-CoV-2 vaccines, including those that may provide cross-variant protection or block transmission. SARS-CoV-2 controlled human infection models (CHIMs) may therefore identify correlates of protection and accelerate the development of new interventions. Methods Healthy vaccinated adults aged 18-30 years were inoculated intranasally in a stepwise dose-escalation CHIM with doses from 1x102 TCID50 to 1x106 TCID50 of SARS-CoV-2 Delta variant. Within the 1x106 TCID50 group, participants were selected for serum neutralising antibody titres (NT50) less than or equal to 1:80. Post-inoculation, participants were quarantined for up to 14 days. Outpatient follow-up continued for 12 months. The primary aim was to elicit safe, well-tolerated Delta SARS-CoV-2 breakthrough infection at a rate of over 50%. Findings Forty-six participants were inoculated; 22 during dose-escalation with no resultant infections, and 24 at the highest dose, of whom 18 were screened for low serum neutralising antibodies. Sustained infection with mild-to-mod","category":"infectious diseases","published_at":"2026-07-28T00:00:00.000Z","corresponding_author":"Christopher Chiu","journal_published_doi":null,"corresponding_institution":"Imperial"},"public_metadata":null,"published_at":"2026-07-31T01:11:47.790Z"},{"id":"cms88yu0xb4ffkh0cdu0fi96r","channel":"knowledge","topic":"papers-medrxiv","title":"Agentic Artificial Intelligence as a Catalyst for Administrative Modernization: The Beginning of the End for Traditional Fax Workflows in Healthcare","summary":"Background: Healthcare has witnessed administrative staffing roles balloon to twice the number of employed clinicians, resulting in $950 billion per year in administrative costs to deliver healthcare. Administrative workflows, like fax routing, are ripe for automation given the high human labor cost","payload":{"doi":"10.64898/2026.07.27.26359032","url":"https://www.medrxiv.org/content/10.64898/2026.07.27.26359032v1","title":"Agentic Artificial Intelligence as a Catalyst for Administrative Modernization: The Beginning of the End for Traditional Fax Workflows in Healthcare","source":"medrxiv","authors":"Lin, A. L.; Curtis, S.; Fitzsimmons, M.; Nguyen, N.; Baqui, A.; Desai, A.; Stalker, L.; Aycock, N.; Koneru, S.; Sridharan, B.; Phillips, H.; Vemulapalli, S.; Patel, M. R.","version":"1","abstract":"Background: Healthcare has witnessed administrative staffing roles balloon to twice the number of employed clinicians, resulting in $950 billion per year in administrative costs to deliver healthcare. Administrative workflows, like fax routing, are ripe for automation given the high human labor cost necessary to complete these tasks. Facsimile transmissions remain a key mode of communication in modern healthcare, requiring substantial manpower, and incurring significant, though not well-characterized, costs to health systems. Opportunities may exist for agentic artificial intelligence (AI) to automate this administrative task. Methods: This quality improvement study was performed in 2 phases at Duke University's Division of Cardiology, a single tertiary-care cardiac referral center. The first retrospective phase employed an observational time study design surveying manual fax routing processes at 3 representative cardiology clinics from April 1, 2024, to July 12, 2024. The second phase quantified all inbound faxes received through the division's communication hub from July 1, 2025, to December 31, 2025, and applied direct labor costs observed in the time study to quantify the econo","category":"health systems and quality improvement","published_at":"2026-07-28T00:00:00.000Z","corresponding_author":"Anthony L. Lin","journal_published_doi":null,"corresponding_institution":"Duke University Health System"},"public_metadata":null,"published_at":"2026-07-31T01:11:47.073Z"},{"id":"cms88yth2b4fdkh0cyauz7hj2","channel":"knowledge","topic":"papers-medrxiv","title":"Rapid diagnosis of fever etiology using wearable temperature monitoring and machine learning","summary":"Introduction. Distinct temperature patterns have long been recognized to correlate with fevers of differing etiologies. While the use of wearable sensors for high-frequency temperature monitoring (HFTM) on a near minute-by-minute basis has been shown to detect fevers earlier than standard-of-care nu","payload":{"doi":"10.64898/2026.07.27.26359010","url":"https://www.medrxiv.org/content/10.64898/2026.07.27.26359010v1","title":"Rapid diagnosis of fever etiology using wearable temperature monitoring and machine learning","source":"medrxiv","authors":"Khan, S. N.; Lee, S.; Ren, X.; Wittrup, E.; Madhukar, R.; Flora, C.; Mayhew, K.; Rozwadowski, M.; Winnega, E.; Leopold, K.; Weinberg, J. B.; Paludo, J.; Binder, A. F.; Ghosh, M.; Frame, D.; Craig, E.; Braun, T. M.; Chanderraj, R.; Sung, A. D.; Najarian, K.; Choi, S. W.; Tewari, M.","version":"1","abstract":"Introduction. Distinct temperature patterns have long been recognized to correlate with fevers of differing etiologies. While the use of wearable sensors for high-frequency temperature monitoring (HFTM) on a near minute-by-minute basis has been shown to detect fevers earlier than standard-of-care nursing vital sign assessments in hospitalized patients, leveraging these high-resolution datasets to computationally identify unique digital signatures for real-time diagnosis of underlying fever etiology has not been widely explored. Diagnostic uncertainty is common in patients undergoing hematopoietic stem cell transplantation (HCT), with only 20-30% of febrile neutropenic episodes being microbiologically documented. We hypothesized that unique temperature patterns extracted from HFTM data collected during episodes of febrile neutropenia could be used to develop a supervised machine learning classifier capable of accurately predicting underlying fever etiology in HCT patients. Methods. We analyzed 68 clinically independent fever episodes recorded in HCT patients (n=90) outfitted with an FDA-cleared wireless temperature sensor (TempTraq(R), BlueSpark Technologies) that measured axillary ","category":"health informatics","published_at":"2026-07-28T00:00:00.000Z","corresponding_author":"Muneesh Tewari","journal_published_doi":null,"corresponding_institution":"University of Michigan"},"public_metadata":null,"published_at":"2026-07-31T01:11:46.358Z"},{"id":"cms88ysxhb4fbkh0cukca8bob","channel":"knowledge","topic":"papers-medrxiv","title":"When Do Drug Shortages Raise Acquisition Costs? Average Duration Effects and Heterogeneous Price Pass-Through","summary":"Drug shortages represent persistent supply disruptions in the U.S. pharmaceutical market, threatening patient access and increasing drug costs. Prior research commonly treats shortages as binary events and relies on static designs, limiting insight into how shortage characteristics drive cost escala","payload":{"doi":"10.64898/2026.07.27.26359030","url":"https://www.medrxiv.org/content/10.64898/2026.07.27.26359030v1","title":"When Do Drug Shortages Raise Acquisition Costs? Average Duration Effects and Heterogeneous Price Pass-Through","source":"medrxiv","authors":"Li, Q.; Repalle, G. S. R.","version":"1","abstract":"Drug shortages represent persistent supply disruptions in the U.S. pharmaceutical market, threatening patient access and increasing drug costs. Prior research commonly treats shortages as binary events and relies on static designs, limiting insight into how shortage characteristics drive cost escalation. This study uncovers the heterogeneity behind drug shortages and pharmacy acquisition costs of generic non-injectable drugs. FDA drug shortage records with weekly National Average Drug Acquisition Cost (NADAC) prices were fit with fixed-effects models, duration-specific models, and a double machine-learning framework to characterize heterogeneity in shortage-price associations by duration, market structure, and shortage reasons. In the baseline two-way fixed-effects model, active shortage designation alone was not associated with a significant increase in NADAC under clustered standard errors. In duration-specific models, shortages lasting more than four consecutive weeks were associated with approximately 7% higher NADAC, while each additional cumulative shortage week was associated with approximately 0.37% higher NADAC. Estimated CATEs varied widely across drugs in each week. Allo","category":"health economics","published_at":"2026-07-28T00:00:00.000Z","corresponding_author":"Qiaoyuan Li","journal_published_doi":null,"corresponding_institution":"UC Berkeley"},"public_metadata":null,"published_at":"2026-07-31T01:11:45.653Z"},{"id":"cms88ysd0b4f9kh0cliw62xj9","channel":"knowledge","topic":"papers-medrxiv","title":"When Cuts Cost More: Projected Fiscal Impact of Eliminating the AIDS Drug Assistance Program in 30 US States","summary":"Across 30 US states and the District of Columbia, eliminating the AIDS Drug Assistance Program is projected to save $8.32 billion in direct costs while generating $14.89 billion in downstream HIV care costs attributable to excess incident infections from 2026-2035. Costs are projected to surpass sav","payload":{"doi":"10.64898/2026.07.27.26359045","url":"https://www.medrxiv.org/content/10.64898/2026.07.27.26359045v1","title":"When Cuts Cost More: Projected Fiscal Impact of Eliminating the AIDS Drug Assistance Program in 30 US States","source":"medrxiv","authors":"Forster, R. M.; Schnure, M.; Balasubramanian, R.; Jones, J. L.; Hyle, E. P.; Batey, S.; Althoff, K. N.; Gebo, K.; Dowdy, D.; Shah, M.; Fojo, A. T.; Kasaie, P.","version":"1","abstract":"Across 30 US states and the District of Columbia, eliminating the AIDS Drug Assistance Program is projected to save $8.32 billion in direct costs while generating $14.89 billion in downstream HIV care costs attributable to excess incident infections from 2026-2035. Costs are projected to surpass savings within six years.","category":"health economics","published_at":"2026-07-28T00:00:00.000Z","corresponding_author":"Parastu Kasaie","journal_published_doi":null,"corresponding_institution":"Johns Hopkins Bloomberg School of Public Health"},"public_metadata":null,"published_at":"2026-07-31T01:11:44.915Z"},{"id":"cms88yrsxb4f7kh0c6r86lim2","channel":"knowledge","topic":"papers-medrxiv","title":"Germline NF2 variant position constrains somatic second hits and determines clinical severity in Neurofibromatosis Type 2-related schwannomatosis","summary":"PurposeNeurofibromatosis type 2-related schwannomatosis (NF2-SWN) is an autosomal dominant tumor syndrome with complete penetrance and variable expressivity. Underlying patterns of disease burden and severity are largely unexplained. MethodsWe comprehensively phenotyped 168 NF2-SWN patients over a m","payload":{"doi":"10.64898/2026.07.27.26359036","url":"https://www.medrxiv.org/content/10.64898/2026.07.27.26359036v1","title":"Germline NF2 variant position constrains somatic second hits and determines clinical severity in Neurofibromatosis Type 2-related schwannomatosis","source":"medrxiv","authors":"Ravindra, N.; Asuzu, D. T.; Celano, E.; Kumar, S.; Chopra, A.; Mandal, D.; Mullaney, D.; Bhatt, D.; Laws, M. T.; Hayes, C.; Kunnath, I.; Sisay, B.; Elkahloun, A.; Asthagiri, A. R.; Lehky, T.; Zalewski, C.; Heiss, J. D.; Kim, H. N.; Chittiboina, P.","version":"1","abstract":"PurposeNeurofibromatosis type 2-related schwannomatosis (NF2-SWN) is an autosomal dominant tumor syndrome with complete penetrance and variable expressivity. Underlying patterns of disease burden and severity are largely unexplained. MethodsWe comprehensively phenotyped 168 NF2-SWN patients over a mean duration of 4.5 years. We used a custom sequencing panel of NF2 and schwannomatosis genes to identify germline (n=166) and somatic variants in tumors (n=37). An optimized composite severity (CSS) score based on clinical and radiological data was created to analyze the effect of genetic variants on phenotype. ResultsWe found significant variable expressivity not explainable by demographic variables. Germline variants included premature termination (42%), splice-site (18%), and large deletions (16%). The CSS successfully predicted worsening clinical function in patients. Unsupervised clustering of clinical data revealed distinct phenotypic clusters that corresponded to CSS. Mosaicism, however, was not associated with CSS or any other disease severity marker. CSS was significantly associated with germline variant location along the NF2 locus. Specifically, FERM-F1 and the -helical varia","category":"oncology","published_at":"2026-07-28T00:00:00.000Z","corresponding_author":"Prashant Chittiboina","journal_published_doi":null,"corresponding_institution":"NINDS"},"public_metadata":null,"published_at":"2026-07-31T01:11:44.193Z"},{"id":"cms88yr9eb4f5kh0c1vocf4ts","channel":"knowledge","topic":"papers-medrxiv","title":"Forty-seven percent of pregnancies have stigmatizing language in their clinical notes in an electronic health record cohort","summary":"Stigmatizing language in medical documentation may reflect and perpetuate bias, but its prevalence in obstetrics has not been systematically quantified. We applied a keyword-guided BERT classifier to 640,345 obstetric notes from 26,178 pregnancies at an academic medical center. Stigmatizing language","payload":{"doi":"10.64898/2026.07.27.26359049","url":"https://www.medrxiv.org/content/10.64898/2026.07.27.26359049v1","title":"Forty-seven percent of pregnancies have stigmatizing language in their clinical notes in an electronic health record cohort","source":"medrxiv","authors":"Simha, N.; Takasuka, H.; Chen, L.-C.; Khan, U.; Oskotsky, T. T.; Sirota, M.; Capra, J. A.; Chen, I. Y.","version":"1","abstract":"Stigmatizing language in medical documentation may reflect and perpetuate bias, but its prevalence in obstetrics has not been systematically quantified. We applied a keyword-guided BERT classifier to 640,345 obstetric notes from 26,178 pregnancies at an academic medical center. Stigmatizing language was detected in 47% of 26,178 pregnancies. Black pregnancies had significantly higher odds of stigmatizing language compared with Asian (aOR=1.5, p=3x10-8) or White (aOR=1.4, p=6x10-6). Indicated and spontaneous preterm births were also significantly associated with stigmatizing language compared to term (aORs=1.5, 1.2; p=7x10-12, 0.01). Pregnant individuals with only 12th-grade maternal education were more likely to experience stigma than those with college (aOR=1.5; p=4x10-14). These findings provide evidence of differences in clinical documentation across race, education levels, and clinical conditions. They also demonstrate how automated natural language processing can enable systematic monitoring of bias in healthcare language at scale.","category":"obstetrics and gynecology","published_at":"2026-07-28T00:00:00.000Z","corresponding_author":"Irene Y Chen","journal_published_doi":null,"corresponding_institution":"Department of Computational Precision Health, UCSF and UC Berkeley, San Francisco and Berkeley, USA"},"public_metadata":null,"published_at":"2026-07-31T01:11:43.490Z"},{"id":"cms88yqpsb4f3kh0cp0tsothk","channel":"knowledge","topic":"papers-medrxiv","title":"Patterns of Gabapentin Use in Patients With Cervical Spondylotic Myelopathy","summary":"Cervical spondylotic myelopathy (CSM) is the most common cause of nontraumatic spinal cord dysfunction in adults and is an increasingly important source of disability as populations age. Gabapentin is widely prescribed for neuropathic pain and may therefore be used for symptoms related to known or u","payload":{"doi":"10.64898/2026.07.27.26358977","url":"https://www.medrxiv.org/content/10.64898/2026.07.27.26358977v1","title":"Patterns of Gabapentin Use in Patients With Cervical Spondylotic Myelopathy","source":"medrxiv","authors":"Warner, B. C.; Arkam, F.; Yakdan, S.; Hammo, A.; Ray, W. Z.; Wilcox, A.; Foraker, R.; Lu, C.; Greenberg, J. K.","version":"1","abstract":"Cervical spondylotic myelopathy (CSM) is the most common cause of nontraumatic spinal cord dysfunction in adults and is an increasingly important source of disability as populations age. Gabapentin is widely prescribed for neuropathic pain and may therefore be used for symptoms related to known or undiagnosed CSM. However, there is sparse evidence related specifically to gabapentin's use for CSM-related pain. We investigate gabapentin use and trends over time in patients with CSM compared to matched controls. We observed that gabapentin prescriptions were higher in CSM patients compared to controls across two multi-hospital datasets. These results highlight the need for further research into pharmacologic treatment for chronic pain in CSM.","category":"neurology","published_at":"2026-07-28T00:00:00.000Z","corresponding_author":"Jacob K Greenberg","journal_published_doi":null,"corresponding_institution":"Washington University in St. Louis"},"public_metadata":null,"published_at":"2026-07-31T01:11:42.784Z"},{"id":"cms88yq6sb4f1kh0cqjb3lx5y","channel":"knowledge","topic":"papers-medrxiv","title":"Multimodal Sleep Physiology Reconstructs Cerebrospinal Fluid Dynamics: A Candidate Digital Biomarker from Noninvasive Sensing","summary":"Cerebrospinal fluid (CSF) dynamics are clinically important but can presently be measured only with expensive, non-portable imaging or invasive monitoring, precluding scalable assessment. We investigated whether CSF flow in the cerebral aqueduct can be reconstructed from noninvasive physiology recor","payload":{"doi":"10.64898/2026.07.27.26359039","url":"https://www.medrxiv.org/content/10.64898/2026.07.27.26359039v1","title":"Multimodal Sleep Physiology Reconstructs Cerebrospinal Fluid Dynamics: A Candidate Digital Biomarker from Noninvasive Sensing","source":"medrxiv","authors":"Banta, A. R.; Phillips, R. A.; D'Ambrosio, R.; Karmonik, C.; Golanov, E.; Regnier-Golanov, A.; Shaib, F.; Britz, G. W.; Aazhang, B.","version":"1","abstract":"Cerebrospinal fluid (CSF) dynamics are clinically important but can presently be measured only with expensive, non-portable imaging or invasive monitoring, precluding scalable assessment. We investigated whether CSF flow in the cerebral aqueduct can be reconstructed from noninvasive physiology recorded during sleep. In 22 healthy adults, with independent validation in 14 additional adults, regularized linear and ensemble regressors predicted the cardiac-cycle CSF flow waveform from electrocardiography, photoplethysmography (PPG), respiration, and electroencephalography acquired during overnight polysomnography, using 7-Tesla phase-contrast MRI as ground truth. Waveforms were reconstructed with high fidelity and generalized to the validation cohort, and deriving physiological metrics from the reconstructed waveform estimated peak velocity more accurately than predicting it directly. A minimal, wearable-oriented PPG feature set retained performance. These results support the feasibility of a noninvasive, potentially wearable digital biomarker of CSF dynamics and motivate evaluation in neurological disease populations.","category":"neurology","published_at":"2026-07-28T00:00:00.000Z","corresponding_author":"Anton Reza Banta","journal_published_doi":null,"corresponding_institution":"Houston Methodist Academic Institute"},"public_metadata":null,"published_at":"2026-07-31T01:11:42.100Z"},{"id":"cms88ypnxb4ezkh0cwevdxgue","channel":"knowledge","topic":"papers-medrxiv","title":"Phase One Development of a Patient-Reported Outcome Measure for Low Anterior Resection Syndrome","summary":"Background The Low Anterior Resection Syndrome (LARS) score is an internationally validated instrument for identifying bowel dysfunction following anterior resection for rectal cancer. Although widely used, it has been shown to have limited sensitivity for capturing the impact of LARS on daily-life ","payload":{"doi":"10.64898/2026.07.27.26359019","url":"https://www.medrxiv.org/content/10.64898/2026.07.27.26359019v1","title":"Phase One Development of a Patient-Reported Outcome Measure for Low Anterior Resection Syndrome","source":"medrxiv","authors":"Farrow, E.; Coxon-Meggy, A.; Knight, L.; Bissett, I.; Bordeianou, L.; Boutros, M.; Burch, J.; Christensen, P.; Corrigan, N.; Croft, J.; Demian, M.; Dhadlie, S.; Emmertsen, K. J.; Gordon, K.; Sarah Faris-Sabboobeh, S.; Fearnhead, N.; Flavio FioreJr, J.; Keane, C.; Knowles, C.; Lloydwin, C.; Marinello, F.; Meggy, A.; Mohan, H.; Ng, K.-S.; Oliveira, C. L. P.; Oliveira, L.; Quyn, A.; Rose, A.; Stocken, D.; Warwick, A.; White, J.; Cornish, J.","version":"1","abstract":"Background The Low Anterior Resection Syndrome (LARS) score is an internationally validated instrument for identifying bowel dysfunction following anterior resection for rectal cancer. Although widely used, it has been shown to have limited sensitivity for capturing the impact of LARS on daily-life and response to treatment. We have therefore developed a novel patient-reported outcome measure (PROM): the LARS Impact and Consequences Assessment Tool (LARS-ICAT). Methods Initial development of LARS-ICAT followed a five-stage process following established PROM development guidance. Stage one established the conceptual foundation through previously published Delphi consensus. Stage two involved item generation, followed by evaluation of content validity through patient focus groups (n=11) in stage three. Stage four comprised iterative expert review and refinement through clinical consensus with patient involvement. Stage five involved cognitive interviews with patients conducted across five rounds (n=23). Results Several items identified through the Delphi consensus were reworded as they included multiple concepts. A one-month recall period was selected, with six and four response opti","category":"surgery","published_at":"2026-07-28T00:00:00.000Z","corresponding_author":"Emily Farrow","journal_published_doi":null,"corresponding_institution":"School of Medicine, Cardiff University, Cardiff, UK"},"public_metadata":null,"published_at":"2026-07-31T01:11:41.422Z"},{"id":"cms88yp5bb4exkh0cksxoho23","channel":"knowledge","topic":"papers-medrxiv","title":"Stroke Knowledge and Its Determinants Among At-Risk Middle-Aged Adults in a Semi-Urban Nigerian Community","summary":"Background: Stroke is a leading cause of premature mortality and disability in sub-Saharan Africa. Effective prevention depends on timely recognition of stroke symptoms and awareness of its risk factors. This study assessed stroke knowledge and its independent predictors among at-risk middle-aged ad","payload":{"doi":"10.64898/2026.07.26.26358987","url":"https://www.medrxiv.org/content/10.64898/2026.07.26.26358987v1","title":"Stroke Knowledge and Its Determinants Among At-Risk Middle-Aged Adults in a Semi-Urban Nigerian Community","source":"medrxiv","authors":"Ubaka, C. M.; Ikeanyi, C. N.; Odeke, D. A.; Ugochukwu, E. J.; Eshiet, U.; Isah, A.","version":"1","abstract":"Background: Stroke is a leading cause of premature mortality and disability in sub-Saharan Africa. Effective prevention depends on timely recognition of stroke symptoms and awareness of its risk factors. This study assessed stroke knowledge and its independent predictors among at-risk middle-aged adults in a semi-urban Nigerian community. Methods: A community-based cross-sectional study was conducted among 316 adults aged 40-65 years using interviewer-administered questionnaires. Stroke knowledge was defined as adequate recognition of both stroke symptoms and risk factors. Pearson's chi-square test and multivariable binary logistic regression were used to identify independent predictors of combined stroke knowledge. Results: Although 296 (93.7%) respondents were aware of stroke, only 112 (35.4%) demonstrated good combined knowledge of stroke symptoms and risk factors. Sudden weakness of face, arm, or leg was the most correctly identified symptom (78{middle dot}6%), while sudden visual disturbance (34{middle dot}1%) and severe headache (37{middle dot}6%) were poorly recognized. Hypertension was the most identified risk factor (87{middle dot}6%), but atrial fibrillation (32{middle do","category":"public and global health","published_at":"2026-07-28T00:00:00.000Z","corresponding_author":"Chukwuemeka  Michael Ubaka","journal_published_doi":null,"corresponding_institution":"University of Nigeria Faculty of Pharmaceutical Sciences"},"public_metadata":null,"published_at":"2026-07-31T01:11:40.751Z"},{"id":"cms88yomsb4evkh0cjj8dp3ks","channel":"knowledge","topic":"papers-medrxiv","title":"Normative EEG Effective Connectivity as a Neural Marker of Autism Spectrum Disorder","summary":"Autism spectrum disorder (ASD) is one of the most common neurodevelopmental disorders. The absence of a clear aetiology strengthens the need to identify quantitative biomarkers capable of diagnosing the condition and assessing the severity of symptoms. We implemented a normative modelling framework ","payload":{"doi":"10.64898/2026.07.27.26359031","url":"https://www.medrxiv.org/content/10.64898/2026.07.27.26359031v1","title":"Normative EEG Effective Connectivity as a Neural Marker of Autism Spectrum Disorder","source":"medrxiv","authors":"Amato, L. G.; Fattorini, F.; Vergani, A. A.; Pagani, M.; Meneghetti, N.; Mazzoni, A.; Fabbrizzi, M.","version":"1","abstract":"Autism spectrum disorder (ASD) is one of the most common neurodevelopmental disorders. The absence of a clear aetiology strengthens the need to identify quantitative biomarkers capable of diagnosing the condition and assessing the severity of symptoms. We implemented a normative modelling framework based on EEG effective connectivity (EC), leveraging recordings collected in three centers, in typical development (TD) and ASD participants with age spanning from 5 to 19 years. Deviations from the normative evolution were tested as ASD biomarkers, compared with standard EC metrics. Normative EC metrics supported accurate classification of ASD vs TD participants (0.82 AUC), reaching 0.95 AUC when combined with behavioral subscales, significantly outperforming a classification based on behavioral data alone. In ASD participants, selected metrics in the Temporo-Parietal-Frontal network predicted social responsiveness scale (SRS) values with high significance (SRS Total R^2=0.42, p=0.0005). These results suggest that normative EC values constitute robust and generalizable ASD biomarkers.","category":"psychiatry and clinical psychology","published_at":"2026-07-28T00:00:00.000Z","corresponding_author":"Lorenzo Gaetano Amato","journal_published_doi":null,"corresponding_institution":"Scuola Superiore Sant'Anna"},"public_metadata":null,"published_at":"2026-07-31T01:11:40.084Z"},{"id":"cms88yo47b4etkh0c7afps0yg","channel":"knowledge","topic":"papers-medrxiv","title":"TSPO PET binding in vivo reflects increased phagocytic microglia at post mortem in people with frontotemporal dementia","summary":"Brain inflammation is a key feature of frontotemporal dementia (FTD). TSPO PET is widely used as an in vivo proxy for neuroinflammation, but whether the elevated signal reflects microglial, astrocytic, or vascular pathology is controversial. We paired ante mortem [11C]PK11195 TSPO PET with post mort","payload":{"doi":"10.64898/2026.06.22.26356176","url":"https://www.medrxiv.org/content/10.64898/2026.06.22.26356176v2","title":"TSPO PET binding in vivo reflects increased phagocytic microglia at post mortem in people with frontotemporal dementia","source":"medrxiv","authors":"Vontobel, D. S.; Lai, K. O.; Bacioglu, M.; Nolan, G.; Maddison, D. C.; Adamski, A.; Goddard, J.; Shapiro, N. L.; Crook, H.; Fryer, T.; Hong, Y.; Wijesinghe, S.; Aigbirhio, F.; Avezov, E.; Allinson, K. S. J.; Quaegebeur, A.; O'Brien, J. T.; Rowe, J. B.; Spillantini, M. G.; Malpetti, M.","version":"2","abstract":"Brain inflammation is a key feature of frontotemporal dementia (FTD). TSPO PET is widely used as an in vivo proxy for neuroinflammation, but whether the elevated signal reflects microglial, astrocytic, or vascular pathology is controversial. We paired ante mortem [11C]PK11195 TSPO PET with post mortem neuropathology in 10 individuals with FTD (5 FTLD-tau, 5 FTLD-TDP) and 5 controls, combining CD68 immunohistochemistry across 17 regions, multiplex immunofluorescence pairing TSPO with microglial/macrophagic (IBA1, CD68), astrocytic (GFAP) and endothelial (CD31) markers, and three-dimensional single-cell reconstruction. CD68 burden was elevated in FTD, concentrated in white matter, and correlated with regional TSPO PET binding across pathologies ({beta} = 8.40, P < 0.001). Only the CD68-TSPO co-localised fraction tracked the PET signal, with no TSPO upregulation per-cell. The elevated TSPO PET signal in FTD likely reflects an increased burden of lysosome-enriched CD68+ microglia, supporting TSPO PET as a microglial-burden biomarker in both FTLD-tau and FTLD-TDP.","category":"pathology","published_at":"2026-07-28T00:00:00.000Z","corresponding_author":"Maura Malpetti","journal_published_doi":null,"corresponding_institution":"1 Department of Clinical Neurosciences, University of Cambridge 2 UK Dementia Research Institute, University of Cambridge 4 Cambridge University Hospitals NHS T"},"public_metadata":null,"published_at":"2026-07-31T01:11:39.415Z"},{"id":"cms88ynlob4erkh0c1fqjsnmp","channel":"knowledge","topic":"papers-medrxiv","title":"Histological triage of early-stage mycosis fungoides using a weakly supervised deep learning-based model: a multicentre, external validation, and clinical utility study","summary":"Background Histological diagnosis of early-stage mycosis fungoides (MF) is hindered by profound overlap with benign inflammatory dermatoses (BIDs), leading to diagnostic delays and extensive ancillary testing. We developed MIMIC (Multiple Instance-learning for Identification of Mycosis fungoides In ","payload":{"doi":"10.64898/2026.07.27.26359009","url":"https://www.medrxiv.org/content/10.64898/2026.07.27.26359009v1","title":"Histological triage of early-stage mycosis fungoides using a weakly supervised deep learning-based model: a multicentre, external validation, and clinical utility study","source":"medrxiv","authors":"Doeleman, T.; Brussee, S.; Valkema, P.; Kempf, W.; Vermeer, M.; Kers, J.; Wynaendts, L.; Kerckhoffs, K.; de Jonge, M.; Nguyen, A.; Peters, E.; Wobser, M.; Rauert-Wunderlich, H.; Rosenwald, A.; Stadler, R.; Jansen, P.; Battistella, M.; Roccuzzo, G.; Quaglino, P.; Schrader, A.","version":"1","abstract":"Background Histological diagnosis of early-stage mycosis fungoides (MF) is hindered by profound overlap with benign inflammatory dermatoses (BIDs), leading to diagnostic delays and extensive ancillary testing. We developed MIMIC (Multiple Instance-learning for Identification of Mycosis fungoides In Cutaneous biopsies), a weakly supervised deep learning model designed as a triage tool at initial H&E whole slide image (WSI) review to distinguish classic patch and plaque stage MF from BIDs. We externally validated the model and evaluated its clinical utility. Methods In this retrospective multicentre study, we trained a base model using weakly supervised attention based multiple instance learning on 3,339 WSIs from two Dutch centres. Crucially, all MF training labels were derived from a deeply phenotyped national cohort featuring strict multidisciplinary expert panel consensus diagnoses (the clinical gold standard). Transportability was evaluated on 371 WSIs from four independent European centres. A blinded reader study on 171 WSIs compared morphology only performance of MIMIC with 11 (dermato-)pathologists. We then retrained an updated model on all retrospective multicentre data and ","category":"pathology","published_at":"2026-07-28T00:00:00.000Z","corresponding_author":"Thom Doeleman","journal_published_doi":null,"corresponding_institution":"Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands"},"public_metadata":null,"published_at":"2026-07-31T01:11:38.748Z"},{"id":"cms88yn2yb4epkh0cklw7vvsn","channel":"knowledge","topic":"papers-medrxiv","title":"Tryptophan metabolites are associated with gut-brain alterations in functional dyspepsia","summary":"IntroductionDisturbances in the microbiota-gut-brain axis are thought to contribute to the pathophysiology of disorders of gut-brain interaction, including functional dyspepsia (FD), although comprehensive human data remain scarce. We aimed to study the relationships among microbiota-produced metabo","payload":{"doi":"10.1101/2025.11.23.25340799","url":"https://www.medrxiv.org/content/10.1101/2025.11.23.25340799v4","title":"Tryptophan metabolites are associated with gut-brain alterations in functional dyspepsia","source":"medrxiv","authors":"Ceulemans, M.; Wauters, L.; Weltens, N.; Vandermeulen, G.; de Loor, H.; Evenepoel, P.; Tito Tadeo, R. Y.; Vich Vila, A.; Derrien, M.; Dalile, B.; Tack, J.; Verbeke, K.; Raes, J.; Van Oudenhove, L.; Vanuytsel, T.","version":"4","abstract":"IntroductionDisturbances in the microbiota-gut-brain axis are thought to contribute to the pathophysiology of disorders of gut-brain interaction, including functional dyspepsia (FD), although comprehensive human data remain scarce. We aimed to study the relationships among microbiota-produced metabolites including tryptophan metabolites and short-chain fatty acids (SCFA), and functional brain connectivity in FD, in relation to symptomatology. MethodsIn 46 patients with Rome IV-diagnosed FD and 30 healthy controls (HC), targeted metabolomics using chromatography and mass spectrometry was conducted to quantify metabolites in blood, urine, and stool. Associations with gut microbiota and symptomatology were tested using fecal quantitative microbiota profiling and validated symptom questionnaires. Resting-state functional magnetic resonance imaging in 27 patients and 36 HC enabled analysis of functional connectivity in selected brain networks. ResultsPatients with FD exhibited distinct profiles of tryptophan metabolites and SCFA with higher urinary indole-3-acetate (IAA, P=0.018), lower serum kynurenine (P=0.030) and lower plasma propionate (P=0.0055) concentrations. FD-specific metabol","category":"gastroenterology","published_at":"2026-07-28T00:00:00.000Z","corresponding_author":"Tim Vanuytsel","journal_published_doi":null,"corresponding_institution":"Katholieke Universiteit Leuven"},"public_metadata":null,"published_at":"2026-07-31T01:11:38.074Z"},{"id":"cms88ymk1b4enkh0cj529vvre","channel":"knowledge","topic":"papers-medrxiv","title":"Etiology and incidence of diarrhea requiring hospitalization in children under 5 years of age in 31 low- and middle-income countries: findings from the Global Pediatric Diarrhea Surveillance network, 2017-2022","summary":"Diarrhea remains a leading cause of child morbidity and mortality. Improved and ongoing estimates of the etiology of hospitalized pediatric diarrhea in low- and middle-income countries (LMICs) are needed to help prioritize and evaluate the use of existing and upcoming vaccines and interventions. The","payload":{"doi":"10.64898/2026.07.26.26358975","url":"https://www.medrxiv.org/content/10.64898/2026.07.26.26358975v1","title":"Etiology and incidence of diarrhea requiring hospitalization in children under 5 years of age in 31 low- and middle-income countries: findings from the Global Pediatric Diarrhea Surveillance network, 2017-2022","source":"medrxiv","authors":"Soeters, H. M.; Antoni, S.; Iyer, S. S.; Weldegebriel, G.; Biey, J.; Mwenda, J. M.; Rey-Benito, G.; Ortiz, C.; Pastore, R.; Videbaek, D.; Singh, S.; Njambe, E.; Sangal, L.; Dhongde, D.; Grabovac, V.; Logronio, J.; Fahmy, K.; Ghoniem, A.; Armah, G.; Dennis, F. E.; Seheri, M. L.; Magagula, N.; Rakau-Nondela, K.; Fumian, T. M.; Maciel, I. T. A.; Samoilovich, E.; Semeiko, G.; Varghese, T.; Thomas, S.; Bines, J.; Li, D.; Kabir, F.; Liu, J.; Houpt, E. R.; Gautam, R.; Mirza, S. A.; Vinje, J.; Mulders, M. N.; Tate, J. E.; Parashar, U. D.; Platts-Mills, J. A.","version":"1","abstract":"Diarrhea remains a leading cause of child morbidity and mortality. Improved and ongoing estimates of the etiology of hospitalized pediatric diarrhea in low- and middle-income countries (LMICs) are needed to help prioritize and evaluate the use of existing and upcoming vaccines and interventions. The Global Pediatric Diarrhea Surveillance (GPDS) network is a World Health Organization (WHO)-coordinated public health surveillance network investigating the etiology of hospitalized diarrhea among children aged <5 years in LMICs. The GPDS network enrolls children hospitalized with diarrhea at 38 sentinel surveillance sites in 31 LMICs. Randomly selected stool specimens were tested by TaqMan Array Card quantitative reverse-transcription polymerase chain reaction (qPCR) for 16 pathogens associated with diarrhea. We estimated pathogen-specific attributable fractions (AFs) and incidence of diarrheal hospitalizations at the global, regional, and country levels during 3 time periods: 2017-2018, 2019-2020, and 2021-2022, with a focus on the most recent results. During 2017-2022, the GPDS network enrolled 70,750 children aged <5 years hospitalized with diarrhea, of which 16,458 (23.3%) were rand","category":"epidemiology","published_at":"2026-07-28T00:00:00.000Z","corresponding_author":"Heidi  M. Soeters","journal_published_doi":null,"corresponding_institution":"Independent Researcher"},"public_metadata":null,"published_at":"2026-07-31T01:11:37.393Z"},{"id":"cms88ym1eb4elkh0cbkerkhbq","channel":"knowledge","topic":"papers-medrxiv","title":"Prevalence, determinants, and cardiometabolic consequences of overweight and obesity among people with Down syndrome: a systematic review and meta-analysis.","summary":"ObjectiveThis systematic review and meta-analysis synthesised the global prevalence of overweight and obesity in people with Down syndrome (DS) across the lifespan, characterised determinants of excess adiposity, and examined associations with adverse cardiometabolic outcomes. MethodsSix databases w","payload":{"doi":"10.64898/2026.07.25.26358905","url":"https://www.medrxiv.org/content/10.64898/2026.07.25.26358905v1","title":"Prevalence, determinants, and cardiometabolic consequences of overweight and obesity among people with Down syndrome: a systematic review and meta-analysis.","source":"medrxiv","authors":"Nambooze, R.; Pitua, I.; Bongomin, F.; Walakira, E. J.; Hove, G. V.; Schauwer, E. D.","version":"1","abstract":"ObjectiveThis systematic review and meta-analysis synthesised the global prevalence of overweight and obesity in people with Down syndrome (DS) across the lifespan, characterised determinants of excess adiposity, and examined associations with adverse cardiometabolic outcomes. MethodsSix databases were searched without date or language restriction. Two independent reviewers screened studies, extracted data, and assessed quality using the Joanna Briggs Institute Critical Appraisal Checklist for Prevalence Studies. Prevalence was pooled using a random- effects logit model. A pre-specified subgroup analysis by age band was conducted. Publication bias was assessed with Eggers test and certainty of evidence with Grading of Recommendations Assessment, Development and Evaluation (GRADE). ResultsTwenty-six studies (7,840 individuals; 14 countries) were included. The pooled prevalence was 18% (95% CI 15-22%) in children and adolescents, 36% (95% CI 26-47%) in adults, and 30% (95% CI 20-43%) in mixed-age cohorts; the test for subgroup differences was significant ({chi}{superscript 2}{square}= 14.39, p = 0.0007). The overall pooled prevalence was 22% (95% CI 18-26%; prediction interval 7-53%;","category":"endocrinology","published_at":"2026-07-28T00:00:00.000Z","corresponding_author":"Rosemary Nambooze","journal_published_doi":null,"corresponding_institution":"Angel's Center for Children with Special Needs, P.O. Box 98, Nansana, Wakiso District, Uganda"},"public_metadata":null,"published_at":"2026-07-31T01:11:36.722Z"},{"id":"cms88yliob4ejkh0cqj6cqjlf","channel":"knowledge","topic":"papers-medrxiv","title":"Participant Experience with the SpaceLabs 90227 ABPM and SOMNOmedics ABPM Pro Devices","summary":"Ambulatory blood pressure monitoring (ABPM) is recommended for confirming hypertension and assessing out-of-office blood pressure (BP). However, patient burden and device tolerability may limit broader implementation. We compared participant experience with a traditional oscillometric ABPM device an","payload":{"doi":"10.64898/2026.07.27.26359028","url":"https://www.medrxiv.org/content/10.64898/2026.07.27.26359028v1","title":"Participant Experience with the SpaceLabs 90227 ABPM and SOMNOmedics ABPM Pro Devices","source":"medrxiv","authors":"Soddano, J.; Fernandez-Sedano, B.; Shurovi, S.; David, M. L.; Ding, G.; Dansoko, F.; Schwartz, J. E.; Abdalla, M.","version":"1","abstract":"Ambulatory blood pressure monitoring (ABPM) is recommended for confirming hypertension and assessing out-of-office blood pressure (BP). However, patient burden and device tolerability may limit broader implementation. We compared participant experience with a traditional oscillometric ABPM device and a compact cuff-integrated ABPM. The PRO-BP Study was a pilot randomized crossover study of 20 adults in New York City. Participants completed two 24-hour ABPM periods over 7 days using the SpaceLabs 90227 and SOMNOmedics ABPM Pro devices. After each period, participants rated comfort, pain, sleep interference, embarrassment, noise, skin irritation, and interference with daytime activities. Both devices achieved guideline-based recording-quality thresholds. Compared with SpaceLabs, ABPM Pro was associated with greater comfort (median 7.0 [IQR, 5.0-8.5] vs 3.5 [IQR, 2.0-6.5]; P=0.004), less pain (1.5 [0-3.5] vs 5.0 [0.5-7.0]; P=0.003), and less embarrassment (0.5 [0-3.5] vs 3.0 [0-6.0]; P=0.01). Other experience ratings did not differ significantly. Participant experience should be considered alongside recording quality when evaluating validated ambulatory BP monitoring technologies.","category":"cardiovascular medicine","published_at":"2026-07-28T00:00:00.000Z","corresponding_author":"Marwah Abdalla","journal_published_doi":null,"corresponding_institution":"Columbia University Irving Medical Center"},"public_metadata":null,"published_at":"2026-07-31T01:11:36.048Z"},{"id":"cms88yl03b4ehkh0c5fqgt8oh","channel":"knowledge","topic":"papers-medrxiv","title":"Ensuring anatomical specificity in lesion network mapping: a multicentre study of 2,950 stroke patients","summary":"As many neurobehavioural functions rely on distributed brain networks, anatomically diverse brain lesions can cause highly similar neurobehavioural deficits. Lesion network mapping (LNM) builds on this principle to identify symptom-specific brain networks by mapping focal lesions onto a normative fu","payload":{"doi":"10.64898/2026.02.16.26346377","url":"https://www.medrxiv.org/content/10.64898/2026.02.16.26346377v3","title":"Ensuring anatomical specificity in lesion network mapping: a multicentre study of 2,950 stroke patients","source":"medrxiv","authors":"Petersen, M.; Patil, K. R.; Eickhoff, S. B.; Biessels, G. J.; Meta VCI Map Consortium,  ","version":"3","abstract":"As many neurobehavioural functions rely on distributed brain networks, anatomically diverse brain lesions can cause highly similar neurobehavioural deficits. Lesion network mapping (LNM) builds on this principle to identify symptom-specific brain networks by mapping focal lesions onto a normative functional connectome. Recent work, however, questioned the anatomical specificity of LNM, showing that commonly used LNM procedures converge on nonspecific properties of the normative connectome rather than symptom-specific networks. Here, we investigated whether anatomically specific LNM can be achieved through appropriate study design and statistical inference. Using a multicenter dataset of 2,950 stroke patients across 12 cohorts, we compared lesion-derived connectivity maps between patients with and without impairment across six cognitive domains. We evaluated group differences using both permutation of symptom labels and parametric two-sample inference, and additionally examined a one-sample approach similar to what was used in the previous critique. Both two-sample approaches yielded distinct, biologically plausible lesion network maps with evident domain-specific features, and limi","category":"neurology","published_at":"2026-07-28T00:00:00.000Z","corresponding_author":"Marvin Petersen","journal_published_doi":null,"corresponding_institution":"University Medical Center Utrecht"},"public_metadata":null,"published_at":"2026-07-31T01:11:35.380Z"},{"id":"cms88ykhbb4efkh0cucxjbrlm","channel":"knowledge","topic":"papers-medrxiv","title":"Personal protective beliefs and behaviors during the COVID-19 pandemic at a large, multi-campus, public university in Pennsylvania: a cross-sectional survey","summary":"Introduction: The COVID-19 pandemic impacted many higher education institutions. Understanding the personal protective beliefs and behaviors surrounding public health measures such as face masking, social distancing, and handwashing helps to inform public health outreach measures. Objective: This st","payload":{"doi":"10.1101/2024.09.23.24314227","url":"https://www.medrxiv.org/content/10.1101/2024.09.23.24314227v2","title":"Personal protective beliefs and behaviors during the COVID-19 pandemic at a large, multi-campus, public university in Pennsylvania: a cross-sectional survey","source":"medrxiv","authors":"Stachowski Bell, J.; Chen, W.; Kim, R. E.; Murphy, R. P.; Pomerantz, L. D.; Kuruppumullage Don, P.; Long, B. A.","version":"2","abstract":"Introduction: The COVID-19 pandemic impacted many higher education institutions. Understanding the personal protective beliefs and behaviors surrounding public health measures such as face masking, social distancing, and handwashing helps to inform public health outreach measures. Objective: This study evaluates the beliefs and occurrences of face masking, social distancing, and handwashing behaviors among people at a multi-campus, public university in Pennsylvania. Methods: From October 5-November 30, 2021, a 10-minute REDCap survey was available to students, faculty, and staff 18 years of age and older at the Pennsylvania State University (PSU). Recruitment included targeted email, social media, digital advertisements, and university newspapers. 4,231 responses were received. Simple percentage associations between the selected factors and face masking behaviors as well as beliefs on the origin of the COVID-19 virus were made with IBM SPSS Statistics, version 29.0.2.0 (20). Results: Of 3,662 completed surveys, 65.2% of respondents were positive that facemasks prevented the transmission of airborne disease, 49.9% of the respondents stated that they wore facemasks always (27.9%), al","category":"public and global health","published_at":"2026-07-28T00:00:00.000Z","corresponding_author":"Bradley A Long","journal_published_doi":null,"corresponding_institution":"Pennsylvania State University"},"public_metadata":null,"published_at":"2026-07-31T01:11:34.704Z"},{"id":"cms88yjxib4edkh0cpr3pe6vw","channel":"knowledge","topic":"papers-medrxiv","title":"SSRI treatment of obsessive-compulsive disorder as motion across a bistable fold: A calibrated circuit-plasticity model of response, remission, and augmentation","summary":"SSRIs are first-line for obsessive-compulsive disorder (OCD), yet benefit is partial, weeks-delayed, and severity-gated, and augmentation is empirical. The stable-states view is established but not drug-specific. We supply the missing coupling: a calibrated object joining serotonin pharmacokinetics,","payload":{"doi":"10.64898/2026.07.24.26358842","url":"https://www.medrxiv.org/content/10.64898/2026.07.24.26358842v3","title":"SSRI treatment of obsessive-compulsive disorder as motion across a bistable fold: A calibrated circuit-plasticity model of response, remission, and augmentation","source":"medrxiv","authors":"Sundaresan, S.","version":"3","abstract":"SSRIs are first-line for obsessive-compulsive disorder (OCD), yet benefit is partial, weeks-delayed, and severity-gated, and augmentation is empirical. The stable-states view is established but not drug-specific. We supply the missing coupling: a calibrated object joining serotonin pharmacokinetics, a basal-ganglia-thalamocortical circuit, and corticostriatal plasticity, in which OCD is an elevated fixed point and SSRI treatment moves this bistable state across a saddle-node fold (a tipping point). With [~]35 constants fixed, two shared parameters reproduce six SSRIs (RMS 0.83 Y-BOCS points, 84 arm-timepoints) and predict a held-out trial (0.58). A fold-free model fits the means equally well, so the mean cannot separate them; they diverge only on individual-level signatures it cannot produce -- a discrete, durable off-drug remission subgroup and critical slowing -- with qualitative support in OCD and adjacent disorders, not yet tested as bistability signatures. These, not the mean, decide who remits and relapses; the same geometry reframes memantine and antipsychotic augmentation.","category":"psychiatry and clinical psychology","published_at":"2026-07-28T00:00:00.000Z","corresponding_author":"Sankaran Sundaresan","journal_published_doi":null,"corresponding_institution":"Princeton University"},"public_metadata":null,"published_at":"2026-07-31T01:11:33.990Z"}]